Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec 31:4:412.
doi: 10.3389/fmicb.2013.00412.

Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides

Affiliations
Review

Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides

Letícia S Tavares et al. Front Microbiol. .

Abstract

The increasing number of antibiotic resistant bacteria motivates prospective research toward discovery of new antimicrobial active substances. There are, however, controversies concerning the cost-effectiveness of such research with regards to the description of new substances with novel cellular interactions, or description of new uses of existing substances to overcome resistance. Although examination of bacteria isolated from remote locations with limited exposure to humans has revealed an absence of antibiotic resistance genes, it is accepted that these genes were both abundant and diverse in ancient living organisms, as detected in DNA recovered from Pleistocene deposits (30,000 years ago). Indeed, even before the first clinical use of antibiotics more than 60 years ago, resistant organisms had been isolated. Bacteria can exhibit different strategies for resistance against antibiotics. New genetic information may lead to the modification of protein structure affecting the antibiotic carriage into the cell, enzymatic inactivation of drugs, or even modification of cellular structure interfering in the drug-bacteria interaction. There are still plenty of new genes out there in the environment that can be appropriated by putative pathogenic bacteria to resist antimicrobial agents. On the other hand, there are several natural compounds with antibiotic activity that may be used to oppose them. Antimicrobial peptides (AMPs) are molecules which are wide-spread in all forms of life, from multi-cellular organisms to bacterial cells used to interfere with microbial growth. Several AMPs have been shown to be effective against multi-drug resistant bacteria and have low propensity to resistance development, probably due to their unique mode of action, different from well-known antimicrobial drugs. These substances may interact in different ways with bacterial cell membrane, protein synthesis, protein modulation, and protein folding. The analysis of bacterial transcriptome may contribute to the understanding of microbial strategies under different environmental stresses and allows the understanding of their interaction with novel AMPs.

Keywords: NGS applications; antimicrobial peptides; genetic; molecular modeling; resistome; transcription.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic antimicrobial peptides prospecting from the in silico analysis of sequences obtained by next generation sequencing. The demand for new antimicrobials to prevent microbial resistance from multifunctional action encourages the search for AMPs through prediction for next-generation sequencing followed by analysis of bioinformatics and computational modeling in order to produce effective peptides after antimicrobial trials. PDB IDs 3GP6; 1THQ; 2JSO; 3HUM; 2L24; 2KUS; 2LB7; 2NY8.

References

    1. Abachin E., Poyart C., Pellegrini E., Milohanic E., Fiedler F., Berche P., et al. (2002). Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 43, 1–14 10.1046/j.1365-2958.2002.02723.x - DOI - PubMed
    1. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403–410 10.1016/S0022-2836(05)80360-2 - DOI - PubMed
    1. Amaral A. C., Silva O. N., Mundim N. C., de Carvalho M. J., Migliolo L., Leite J. R., et al. (2012). Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics. Peptides 37, 301–308 10.1016/j.peptides.2012.07.021 - DOI - PubMed
    1. Baker D., Sali A. (2001). Protein structure prediction and structural genomics. Science 294, 93–96 10.1126/science.1065659 - DOI - PubMed
    1. Balkis M. M., Leidich S. D., Mukherjee P. D., Ghannoum M. A. (2002). Mechanisms of fungal resistance. Drugs 62, 1025–1040 10.2165/00003495-200262070-00004 - DOI - PubMed

LinkOut - more resources